Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
J&J
Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know
Bhaswati Guha Majumder
Nov 15, 2021 11:06 AM +05:30 IST
J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India
Swarajya Staff
Aug 20, 2021 01:06 PM +05:30 IST
J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In India
Swarajya Staff
Aug 7, 2021 01:48 PM +05:30 IST
US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India
Swarajya Staff
Aug 6, 2021 04:14 PM +05:30 IST
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month
Swarajya Staff
Jun 26, 2021 01:53 PM +05:30 IST
Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra
Swarajya Staff
Apr 20, 2021 06:40 PM +05:30 IST
Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO
IANS
May 30, 2020 01:06 PM +05:30 IST
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants
Swarajya Staff
Mar 11, 2019 10:37 AM +05:30 IST
Load More